Successful TAVI Treatment for 99-year-old Aortic Valve Stenosis Patients A 100-year-old Life Gift
Dec 30, 2024
A team led by Professor Jang Ki-yuk of the Catholic University of Korea's Seoul St. Mary's Hospital Cardio-cerebrovascular Hospital successfully performed percutaneous aortic valve replacement (TAVI) on a 99-year-old patient and presented a 100-year-old life. This case suggests that super-aged patients may be more likely to return to their daily lives after treatment through TAVI procedures.
The yellow (female, 99) patient underwent the first TAVI procedure at the age of 90 for severe aortic valve stenosis on December 19, 2015, and inserted a Sapien XT 23 mm valve. Since then, it has remained stable, but echocardiography in October 2023 confirmed that severe aortic valve stenosis recurred due to degeneration of the existing TAVI valve. As a result, while observing the progress with medication, he visited the emergency room on December 16, 2024, due to worsening heart failure and lung edema and pleural effusion.
Echocardiography performed after the visit confirmed hypertrophic aortic valve stenosis, and while undergoing conservative treatment with pigtail catheterization and diuretic administration, it was determined that additional TAVI procedures were needed as the underlying cause treatment.
Due to the super-aged age of 99, it was necessary for the family to discuss whether to undergo TAVI treatment again or life-sustaining treatment with conservative treatments such as diuretics. After discussion, it was decided to undergo TAVI treatment in consideration of the patient's smooth mobility and daily life.
The patient underwent a second TAVI procedure on December 19 and successfully replaced the aortic valve, and lung edema and pleural effusion disappeared, and he was discharged six days after the procedure due to an increase in the amount of meals and the ability to walk in the ward.
Hwang's family was surprised by the patient's quick recovery and expressed deep gratitude to the medical staff. This case is an achievement made by the TAVI team at Seoul St. Mary's Hospital's rich experience and thorough preparation, and is expected to give hope to elderly heart patients.
Professor Jang Ki-yuk, head of the Cardio-cerebrovascular Hospital at Seoul St. Mary's Hospital, said, "This procedure is an important example that shows that even super-aged patients can be safely treated with percutaneous aortic valve replacement. The usual activity and health status should be more important criteria than age in deciding on the procedure for elderly patients."," he stressed. We will also do our best to provide a new life through safe procedures for patients who have difficulty with heart surgery in the aging era" he said.
The yellow (female, 99) patient underwent the first TAVI procedure at the age of 90 for severe aortic valve stenosis on December 19, 2015, and inserted a Sapien XT 23 mm valve. Since then, it has remained stable, but echocardiography in October 2023 confirmed that severe aortic valve stenosis recurred due to degeneration of the existing TAVI valve. As a result, while observing the progress with medication, he visited the emergency room on December 16, 2024, due to worsening heart failure and lung edema and pleural effusion.
Echocardiography performed after the visit confirmed hypertrophic aortic valve stenosis, and while undergoing conservative treatment with pigtail catheterization and diuretic administration, it was determined that additional TAVI procedures were needed as the underlying cause treatment.
Due to the super-aged age of 99, it was necessary for the family to discuss whether to undergo TAVI treatment again or life-sustaining treatment with conservative treatments such as diuretics. After discussion, it was decided to undergo TAVI treatment in consideration of the patient's smooth mobility and daily life.
The patient underwent a second TAVI procedure on December 19 and successfully replaced the aortic valve, and lung edema and pleural effusion disappeared, and he was discharged six days after the procedure due to an increase in the amount of meals and the ability to walk in the ward.
Hwang's family was surprised by the patient's quick recovery and expressed deep gratitude to the medical staff. This case is an achievement made by the TAVI team at Seoul St. Mary's Hospital's rich experience and thorough preparation, and is expected to give hope to elderly heart patients.
Professor Jang Ki-yuk, head of the Cardio-cerebrovascular Hospital at Seoul St. Mary's Hospital, said, "This procedure is an important example that shows that even super-aged patients can be safely treated with percutaneous aortic valve replacement. The usual activity and health status should be more important criteria than age in deciding on the procedure for elderly patients."," he stressed. We will also do our best to provide a new life through safe procedures for patients who have difficulty with heart surgery in the aging era" he said.
|
This article was translated by Naver AI translator.
